Genpact

Genpact Share Price Pullback: Is It an Opportunity?

简伯特

Genpact's 15min chart shows RSI Overbought, KDJ Death Cross signals.

Genpact's 15min chart triggered Bollinger Bands expanding upward, KDJ Golden Cross

Genpact: Needham maintains Buy, lowers PT to $50 from $53.

Genpact Q4 Profit Climbs to $143.09M, Revenue Rises 5.6% to $1.31B

Catalyst<ul> <li>Strong cash reserves relative to market value indicate solid financial health for G.</li></ul>Risk<ul> <li>Bearish technical signals such as recent Marubozu White patterns indicate downward pressure on G.</li> <li>Fund flows show negative trends across most investment sizes, suggesting declining investor confidence in G.</li> <li>Analysts maintain a Neutral rating for G, reflecting cautious market expectations and diverging views.</li></ul>

Key Factors

Genpact reported Q4 2025 earnings with revenue of $1.32 billion, a 5.6% year-over-year increase, and non-GAAP EPS of $0.97, exceeding forecasts by 3.8%. Genpact's Advanced Technology Solutions revenue rose 17% to $1.204 billion in 2025, representing 24% of total revenue. Genpact cut its Q1 2026 revenue guidance to $1.29 billion, slightly below analyst estimates, causing a 15% stock decline despite a Q4 earnings beat. Needham maintained a Buy rating for Genpact but lowered its price target from $53 to $50. Genpact's stock price fell 20.8% over four weeks, entering oversold territory with an RSI of 18.15.

G News